Non-Hodgkin's Lymphoma News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

UD football 'teammate' needs bone marrow transplant - The News Journal



The News Journal
 
UD football 'teammate' needs bone marrow transplant 
The News Journal
A young boy adopted by the University of Delaware football team in 2012 while being treated for T-cell lymphoblastic lymphoma ? a rare and very aggressive non-Hodgkin's lymphoma ? is now in need of a bone marrow transplant. In late December, four ...

 


DAAs Well Tolerated with Chemotherapy for Comorbid HCV, Non-Hodgkin's Lymphoma - MD Magazine



MD Magazine
 
DAAs Well Tolerated with Chemotherapy for Comorbid HCV, Non-Hodgkin's Lymphoma 
MD Magazine
The investigators recruited 20 consecutive HCV-positive genotype 1b-infected patients affected with diffuse large B-cell lymphoma (DLBCL; 13 male, 7 female) referred to 1 of 3 hepatology clinics for DAA treatment, from hematological treatment centers ...

 


Alabama Democrats see women run for office; GOP struggles - Montgomery Advertiser



Montgomery Advertiser
 
Alabama Democrats see women run for office; GOP struggles 
Montgomery Advertiser
Amy Wasyluka said she never pictured herself running for public office. But several factors pushed Wasyluka, an attorney and cancer survivor, into the political arena. One major factor was health care. Wasyluka was diagnosed with non-Hodgkin's lymphoma ...

 


Forty Seven Inc. Appoints Kristine M. Ball to Board of Directors - Markets Insider



Markets Insider
 
Forty Seven Inc. Appoints Kristine M. Ball to Board of Directors 
Markets Insider
MENLO PARK, Calif., Feb. 20, 2018 /PRNewswire/ -- Forty Seven Inc., a clinical-stage company focused on developing the next generation of transformational immuno-oncology treatments to enable patient's immune systems to defeat their cancer, today ...

and more » 


Money, Money, Money! Europe's Best-Funded Biotechs in 2018 - Labiotech.eu (blog)



Money, Money, Money! Europe's Best-Funded Biotechs in 2018 
Labiotech.eu (blog)
... greatly expanding their potential to treat a wide range of cancers. Their current pipeline boasts 7 candidates at various stages of clinical development, and their most advanced candidate CMD-003, received Orphan Drug status from the FDA in 2015 ...

 


Nordic Nanovector ASA: Invitation to Fourth Quarter and Full Year 2017 Results Presentation and Webcast - Markets Insider



Nordic Nanovector ASA: Invitation to Fourth Quarter and Full Year 2017 Results Presentation and Webcast 
Markets Insider
... is Betalutin®, a novel CD37-targeting Antibody-Radionuclide-Conjugate (ARC) designed to advance the treatment of non-Hodgkin's Lymphoma (NHL). NHL is an indication with substantial unmet medical need, representing a growing market forecast to be ...

and more » 


Axi-Cel and Future of CAR T-Cell Therapy in Lymphoma - OncLive - OncLive



OncLive
 
Axi-Cel and Future of CAR T-Cell Therapy in Lymphoma - OncLive 
OncLive
Sattva S. Neelapu, MD, discusses the safety and practical implications for axi-cel (KTE-C19) as part of the ZUMA-1 trial, as well as the future for CAR T-cellular therapy in lymphoma.

and more » 


Saints' Austin Carr meets the man whose life he saved with his bone marrow - NBCSports.com



NBCSports.com
 
Saints' Austin Carr meets the man whose life he saved with his bone marrow 
NBCSports.com
Saints receiver Austin Carr saved a man's life two years ago, and at the Super Bowl, they met. The man was Roy Coe, and he was dying of non-Hodgkin's lymphoma until Carr gave Coe his bone marrow. Carr had been a football player at Northwestern in 2013 ...

 


Patients with osteosarcoma and soft tissue sarcoma might become "cancer refugees" in some Japanese regional cities - Dove Medical Press



Patients with osteosarcoma and soft tissue sarcoma might become "cancer refugees" in some Japanese regional cities 
Dove Medical Press
Purpose: ?Rare cancer? is defined as malignancy with a disease prevalence (age-adjusted incidence rate) of less than six per 100,000 population. Proper treatments which these patients need cannot always be performed unless they find dedicated ...

 


Burbank High students host fundraiser for blood cancer research - Los Angeles Times



Burbank High students host fundraiser for blood cancer research 
Los Angeles Times
Ryan said she and her classmates are trying to raise $50,000 for the Leukemia & Lymphoma Society, adding that fundraising efforts started in late January. Advertisement. The campaign holds a special place in Ryan's heart. In 2003, her father was ...